Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PAC-1 |
Trade Name | |
Synonyms | VO-100 |
Drug Descriptions |
PAC-1 is a small molecule activator of procaspase 3, which occurs via inhibition of zinc ions, resulting in autoactivation and thus, may lead to apoptotis and anti-tumor activity (PMID: 19281821, PMID: 27297867). |
DrugClasses | |
CAS Registry Number | 315183-21-2 |
NCIT ID | C120318 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Entrectinib + PAC-1 | Entrectinib PAC-1 | 0 | 1 |
PAC-1 | PAC-1 | 0 | 1 |
PAC-1 + Temozolomide | PAC-1 Temozolomide | 0 | 1 |
PAC-1 + Trametinib + Vemurafenib | PAC-1 Trametinib Vemurafenib | 1 | 0 |
PAC-1 + Vemurafenib | PAC-1 Vemurafenib | 1 | 0 |